{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:19:47Z","timestamp":1780633187574,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T00:00:00Z","timestamp":1745712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T00:00:00Z","timestamp":1745712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The current Atrial fibrillation Better Care (ABC) pathway for holistic or integrated management of AF is associated with improved clinical outcomes; however, data on the very elderly (aged\u2009\u2265\u200985 years) are sparse.<\/jats:p>\n          <jats:p>To evaluate the impact of ABC pathway on clinical outcomes amongst very elderly AF patients over a follow-up period of 1 year.<\/jats:p>\n          <jats:p>The ChiOTEAF registry is a prospective, multicenter nationwide study conducted from October 2014 to December 2018. Endpoints of interest were the composite outcome of all-cause death\/any thromboembolism (TE), all-cause death, TE events, and major bleeding.<\/jats:p>\n          <jats:p>The eligible cohort included 1215 individuals (mean age 88.5\u2009\u00b1\u20093.3; 33.5% female), of which 142 (11.7%) were managed accordingly to the ABC pathway. ABC compliance was independently associated with lower odds of the composite outcome (odds Ratio (OR): 0.23; 95% confidence interval (CI): 0.08\u20130.66) and all-cause death (OR: 0.22; 95% CI: 0.07\u20130.75), without a significant increase in major bleeding compared to ABC non-compliance. Health-related quality of life (QOL) was also significantly higher in the ABC compliant group compared to the non-compliant group (EQ score 0.83\u2009\u00b1\u20090.17 vs. 0.78\u2009\u00b1\u20090.20; <jats:italic>p<\/jats:italic> = \u20090.004). Independent predictors of ABC non-compliance were prior major bleeding, chronic kidney disease, and dementia.<\/jats:p>\n          <jats:p>Our findings suggest that adherence to the ABC pathway in very elderly patients is associated with significantly improved survival and health-related QOL.<\/jats:p>","DOI":"10.1007\/s11739-025-03928-0","type":"journal-article","created":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T10:27:50Z","timestamp":1745749670000},"page":"1087-1095","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of the ABC pathway on clinical outcomes in very elderly Chinese patients with atrial fibrillation. A report from the optimal thromboprophylaxis in elderly Chinese patients with atrial fibrillation (ChiOTEAF) registry"],"prefix":"10.1007","volume":"20","author":[{"given":"Ameenathul Mazaya","family":"Fawzy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Kotalczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ChiOTEAF Registry Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,27]]},"reference":[{"key":"3928_CR1","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nrcardio.2017.153","volume":"14","author":"GYH Lip","year":"2017","unstructured":"Lip GYH (2017) The ABC pathway: an integrated approach to improve AF management. Nat Rev Cardiol 14:627\u2013628","journal-title":"Nat Rev Cardiol"},{"key":"3928_CR2","doi-asserted-by":"publisher","unstructured":"Potpara TS, Romiti GF, Sohns C (2024) The 2024 European Society of cardiology guidelines for diagnosis and management of atrial fibrillation: a viewpoint from a practicing clinician\u2019s perspective. Thromb Haemost 124. Epub ahead of print 7 October 2024. https:\/\/doi.org\/10.1055\/A-2434-9244","DOI":"10.1055\/A-2434-9244"},{"key":"3928_CR3","doi-asserted-by":"crossref","unstructured":"Chao TF, Joung B, Takahashi Y et al (2021) Focused update consensus guidelines of the Asia Pacific heart rhythm society on stroke prevention in atrial fibrillation: executive summary. Thromb Haemost 122:20\u201347","DOI":"10.1055\/s-0041-1739411"},{"key":"3928_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N et al (2021) 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) the task force for the diagnosis and management of atrial fibrillation of the European. Eur Heart J 42:373\u2013498","journal-title":"Eur Heart J"},{"key":"3928_CR5","doi-asserted-by":"publisher","unstructured":"Wang Y, Guo Y, Qin M et al (2024) Chinese expert consensus guidelines on the diagnosis and treatment of atrial fibrillation in the elderly, endorsed by geriatric society of Chinese medical association (cardiovascular group) and Chinese Society of Geriatric health medicine (cardiovascular branch): executive summary. Thromb Haemost 124. Epub ahead of print 2024. https:\/\/doi.org\/10.1055\/A-2325-5923","DOI":"10.1055\/A-2325-5923"},{"key":"3928_CR6","doi-asserted-by":"crossref","unstructured":"Van Gelder IC, Rienstra M, Bunting KV et al (2024) ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Eur Heart J 45:3314\u20133414","DOI":"10.1093\/eurheartj\/ehae176"},{"key":"3928_CR7","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/europace\/euaa274","volume":"23","author":"M Proietti","year":"2021","unstructured":"Proietti M, Lip GYH, Laroche C et al (2021) Relation of outcomes to ABC (atrial fibrillation better care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) registry. Europace 23:174\u2013183","journal-title":"Europace"},{"key":"3928_CR8","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.jacc.2020.01.052","volume":"75","author":"Y Guo","year":"2020","unstructured":"Guo Y, Lane DA, Wang L et al (2020) Mobile health technology to improve care for patients with atrial fibrillation. J Am Coll Cardiol 75:1523\u20131534","journal-title":"J Am Coll Cardiol"},{"key":"3928_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014932","volume":"9","author":"M Proietti","year":"2020","unstructured":"Proietti M, Romiti GF, Olshansky B et al (2020) Comprehensive management with the ABC (atrial fibrillation better care) pathway in clinically complex patients with atrial fibrillation: a post hoc ancillary analysis from the AFFIRM trial. J Am Heart Assoc 9:e014932","journal-title":"J Am Heart Assoc"},{"key":"3928_CR10","doi-asserted-by":"publisher","unstructured":"Romiti G, Pastori D, Rivera-Caravaca J et al (2021) Adherence to the \u2018atrial fibrillation better care\u2019 pathway in patients with atrial fibrillation: impact on clinical outcomes\u2014a systematic review and meta-analysis of 285,000 patients. Thromb Haemost. Epub ahead of print 2021. https:\/\/doi.org\/10.1055\/A-1515-9630","DOI":"10.1055\/A-1515-9630"},{"key":"3928_CR11","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1160\/TH17-08-0555","volume":"117","author":"M Mazurek","year":"2017","unstructured":"Mazurek M, Huisman MV, Rothman KJ et al (2017) Regional differences in antithrombotic treatment for atrial fibrillation: insights from the GLORIA-AF phase II registry. Thromb Haemost 117:2376\u20132388","journal-title":"Thromb Haemost"},{"key":"3928_CR12","doi-asserted-by":"publisher","first-page":"e210247","DOI":"10.1001\/jamanetworkopen.2021.0247","volume":"4","author":"LA Eberly","year":"2021","unstructured":"Eberly LA, Garg L, Yang L et al (2021) Racial\/ethnic and socioeconomic disparities in management of incident paroxysmal atrial fibrillation. JAMA Netw Open 4:e210247\u2013e210247","journal-title":"JAMA Netw Open"},{"key":"3928_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100160","volume":"7","author":"A Kotalczyk","year":"2021","unstructured":"Kotalczyk A, Lip GYH (2021) Disparities in atrial fibrillation: a call for holistic care. Lancet Regional Health Europe 7:100160","journal-title":"Lancet Regional Health Europe"},{"key":"3928_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020191","volume":"8","author":"Y Guo","year":"2018","unstructured":"Guo Y, Wang Y, Li X et al (2018) Optimal Thromboprophylaxis in elderly Chinese patients with atrial fibrillation (ChiOTEAF) registry: protocol for a prospective, observational nationwide cohort study. BMJ Open 8:e020191","journal-title":"BMJ Open"},{"key":"3928_CR15","doi-asserted-by":"publisher","unstructured":"Guo Y, Imberti JF, Kotalczyk A et al (2022) Atrial fibrillation better care pathway adherent care improves outcomes in Chinese patients with atrial fibrillation. JACC: Asia. Epub ahead of print 26 April 2022. https:\/\/doi.org\/10.1016\/J.JACASI.2022.01.007","DOI":"10.1016\/J.JACASI.2022.01.007"},{"key":"3928_CR16","doi-asserted-by":"publisher","unstructured":"Guo Y, Kotalczyk A, Imberti JF et al (2021) Oral anticoagulation improves survival in very elderly Chinese patients with atrial fibrillation: a report from the optimal thromboprophylaxis in elderly Chinese patients with atrial fibrillation (ChiOTEAF) registry. Int JStroke. Epub ahead of print 22 Sept 2021. https:\/\/doi.org\/10.1177\/17474930211046743","DOI":"10.1177\/17474930211046743"},{"key":"3928_CR17","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1093\/ageing\/afv071","volume":"44","author":"A Wolff","year":"2015","unstructured":"Wolff A, Shantsila E, Lip GYH et al (2015) Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice. Age Ageing 44:874\u2013878","journal-title":"Age Ageing"},{"key":"3928_CR18","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/europace\/eut373","volume":"16","author":"GYH Lip","year":"2014","unstructured":"Lip GYH, Laroche C, Dan G-A et al (2014) A prospective survey in European society of cardiology member countries of atrial fibrillation management: baseline results of EURObservational research programme atrial fibrillation (EORP-AF) pilot general registry. EP Europace 16:308\u2013319","journal-title":"EP Europace"},{"key":"3928_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GYH Lip","year":"2010","unstructured":"Lip GYH, Nieuwlaat R, Pisters R et al (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation. Chest 137:263\u2013272","journal-title":"Chest"},{"key":"3928_CR20","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R et al (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro heart survey. Chest 138:1093\u20131100","journal-title":"Chest"},{"key":"3928_CR21","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3:692\u2013694","journal-title":"J Thromb Haemost"},{"key":"3928_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/gerona\/glq208","volume":"66","author":"C Diederichs","year":"2011","unstructured":"Diederichs C, Berger K, Bartels DB (2011) The measurement of multiple chronic diseases\u2014a systematic review on existing multimorbidity indices. J Gerontol A Biol Sci Med Sci 66:301\u2013311","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"3928_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3109\/13814789609162146","volume":"2","author":"M van den Akker","year":"1996","unstructured":"van den Akker M, Buntinx F, Knottnerus JA (1996) Comorbidity or multimorbidity. Euro J General Pract 2:65\u201370","journal-title":"Euro J General Pract"},{"key":"3928_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2019.100461","volume":"26","author":"M Kozie\u0142","year":"2020","unstructured":"Kozie\u0142 M, Simovic S, Pavlovic N et al (2020) Management of patients with newly-diagnosed atrial fibrillation: insights from the BALKAN-AF survey. IJC Heart Vasc 26:100461","journal-title":"IJC Heart Vasc"},{"key":"3928_CR25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/europace\/eun369","volume":"11","author":"M Nabauer","year":"2009","unstructured":"Nabauer M, Gerth A, Limbourg T et al (2009) The registry of the German competence network on atrial fibrillation: patient characteristics and initial management. EP Europace 11:423\u2013434","journal-title":"EP Europace"},{"key":"3928_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-022-02965-0","volume":"22","author":"X Xia","year":"2022","unstructured":"Xia X, Wang L, Lin T et al (2022) Barriers to prescribing oral anticoagulants to inpatients aged 80 years and older with nonvalvular atrial fibrillation: a cross-sectional study. BMC Geriatr 22:1\u201310","journal-title":"BMC Geriatr"},{"key":"3928_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/ageing\/afv156","volume":"45","author":"KH Ng","year":"2016","unstructured":"Ng KH, Shestakovska O, Connolly SJ et al (2016) Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial. Age Ageing 45:77\u201383","journal-title":"Age Ageing"},{"key":"3928_CR28","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1055\/s-0040-1718729","volume":"121","author":"HK Kim","year":"2021","unstructured":"Kim HK, Tantry US, Smith SC et al (2021) The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease. Thromb Haemost 121:422\u2013432","journal-title":"Thromb Haemost"},{"key":"3928_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/CIRCULATIONAHA.117.031658","volume":"138","author":"T-F Chao","year":"2018","unstructured":"Chao T-F, Liu C-J, Lin Y-J et al (2018) Oral anticoagulation in very elderly patients with atrial fibrillation. Circulation 138:37\u201347","journal-title":"Circulation"},{"key":"3928_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216831","volume":"14","author":"D Poli","year":"2019","unstructured":"Poli D, Antonucci E, Ageno W et al (2019) Oral anticoagulation in very elderly patients with atrial fibrillation: Results from the prospective multicenter START2-REGISTER study. PLoS ONE 14:e0216831","journal-title":"PLoS ONE"},{"key":"3928_CR31","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1056\/NEJMoa2012883","volume":"383","author":"K Okumura","year":"2020","unstructured":"Okumura K, Akao M, Yoshida T et al (2020) Low-dose edoxaban in very elderly patients with atrial fibrillation. N Engl J Med 383:1735\u20131745","journal-title":"N Engl J Med"},{"key":"3928_CR32","doi-asserted-by":"publisher","unstructured":"Kuroda M, Tamiya E, Nose T et al (2022) Effect of 15-mg Edoxaban on clinical outcomes in 3 age strata in older patients with atrial fibrillation: a prespecified subanalysis of the ELDERCARE-AF randomized clinical trial. JAMA Cardiol 7. Epub ahead of print 2022. https:\/\/doi.org\/10.1001\/JAMACARDIO.2022.0480","DOI":"10.1001\/JAMACARDIO.2022.0480"},{"key":"3928_CR33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.amjopharm.2009.06.002","volume":"7","author":"LG Jacobs","year":"2009","unstructured":"Jacobs LG, Billett HH, Freeman K et al (2009) Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and\/or early-stage dementia: a single-center, retrospective, observational study. Am J Geriatr Pharmacother 7:159\u2013166","journal-title":"Am J Geriatr Pharmacother"},{"key":"3928_CR34","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3233\/JAD-170575","volume":"61","author":"A Subic","year":"2018","unstructured":"Subic A, Cermakova P, Religa D et al (2018) Treatment of atrial fibrillation in patients with dementia: a cohort study from the Swedish dementia registry. J Alzheimers Dis 61:1119\u20131128","journal-title":"J Alzheimers Dis"},{"key":"3928_CR35","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz386","volume":"40","author":"D Kim","year":"2019","unstructured":"Kim D, Yang PS, Yu HT et al (2019) Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort. Eur Heart J 40:2313\u20132323","journal-title":"Eur Heart J"},{"key":"3928_CR36","doi-asserted-by":"publisher","unstructured":"Yang PS, Sung JH, Jang E et al (2020) The effect of integrated care management on dementia in atrial fibrillation. J Clin Med 9. Epub ahead of print 1 June 2020. https:\/\/doi.org\/10.3390\/JCM9061696","DOI":"10.3390\/JCM9061696"},{"key":"3928_CR37","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/joa3.12364","volume":"36","author":"PS Yang","year":"2020","unstructured":"Yang PS, Sung JH, Jang E et al (2020) Application of the simple atrial fibrillation better care pathway for integrated care management in frail patients with atrial fibrillation: a nationwide cohort study. J Arrhythm 36:668\u2013677","journal-title":"J Arrhythm"},{"key":"3928_CR38","doi-asserted-by":"publisher","unstructured":"Proietti M, Vitolo M, Lip GYH (2021) Integrated care and outcomes in patients with atrial fibrillation and comorbidities. Eur J Clin Invest 51. Epub ahead of print 1 June 2021. https:\/\/doi.org\/10.1111\/ECI.13498","DOI":"10.1111\/ECI.13498"},{"key":"3928_CR39","doi-asserted-by":"publisher","unstructured":"Kotalczyk A, Guo Y, Stefil M et al (2022) Effects of the atrial fibrillation better care pathway on outcomes among clinically complex Chinese patients with atrial fibrillation with multimorbidity and polypharmacy: a report from the ChiOTEAF registry. J Am Heart Assoc 11. Epub ahead of print 5 April 2022. https:\/\/doi.org\/10.1161\/JAHA.121.024319","DOI":"10.1161\/JAHA.121.024319"},{"key":"3928_CR40","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1055\/s-0040-1716408","volume":"121","author":"TS Potpara","year":"2021","unstructured":"Potpara TS, Lip GYH, Blomstrom-Lundqvist C et al (2021) The 4S-AF scheme (stroke risk; symptoms; severity of burden; substrate): a novel approach to in-depth characterization (rather than classification) of atrial fibrillation. Thromb Haemost 121:270\u2013278","journal-title":"Thromb Haemost"},{"key":"3928_CR41","doi-asserted-by":"publisher","unstructured":"Kang DS, Yang PS, Kim D et al (2024) Racial differences in bleeding risk: an ecological epidemiological study comparing Korea and United Kingdom subjects. Thromb Haemost 124. Epub ahead of print 2024. https:\/\/doi.org\/10.1055\/A-2269-1123","DOI":"10.1055\/A-2269-1123"},{"key":"3928_CR42","doi-asserted-by":"publisher","unstructured":"Kang DS, Yang PS, Kim D et al (2023) Racial differences in ischemic and hemorrhagic stroke: an ecological epidemiological study. Thromb Haemost. Epub ahead of print 2023. https:\/\/doi.org\/10.1055\/A-2278-8769","DOI":"10.1055\/A-2278-8769"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-025-03928-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-025-03928-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-025-03928-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T12:04:29Z","timestamp":1748865869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-025-03928-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,27]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3928"],"URL":"https:\/\/doi.org\/10.1007\/s11739-025-03928-0","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,27]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GYHL\u2014Consultant and speaker for BMS\/Pfizer, Boehringer Ingelheim, Anthos and Daiichi-Sankyo. No fees are directly received personally. He is co-principal investigator of the AFFIRMO project on multimorbidity in AF, which has received funding from the European Union\u2019s Horizon 2020 research and innovation programme under grant agreement No. 899871. The rest of the authors have none to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Ethics approval was granted by the Central Medical Ethic Committee of Chinese PLA General Hospital (approval no S2014-065-01).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.Authors are responsible for correctness of the statements provided in the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}